These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39307852)

  • 1. In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates.
    Abichabki N; Gaspar GG; Zacharias LV; Pocente RHC; Lima DAFS; de Freitas NAB; Brancini GTP; Moreira NC; Braga GÚL; Bellissimo-Rodrigues F; Bollela VR; Darini ALC; Andrade LN
    Curr Microbiol; 2024 Sep; 81(11):371. PubMed ID: 39307852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
    Borjan J; Meyer KA; Shields RK; Wenzler E
    Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
    Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
    Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance and epidemiological characteristics of polymyxin-resistant
    Chen L; Deng M; Wang J; Wu T; Zhou S; Yang R; Zhang D; Zou M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May; 49(5):737-747. PubMed ID: 39174888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant
    Sturaro MC; Damaceno NdS; Faccin ID; Silva ON; de Aquino TM; Freire NML; Alcântara MGdS; Monteiro KLC; Rossato L; de Souza GHdA; Simionatto S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0093024. PubMed ID: 39254296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
    Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.
    Abichabki N; Zacharias LV; Moreira NC; Bellissimo-Rodrigues F; Moreira FL; Benzi JRL; Ogasawara TMC; Ferreira JC; Ribeiro CM; Pavan FR; Pereira LRL; Brancini GTP; Braga GÚL; Zuardi AW; Hallak JEC; Crippa JAS; Lanchote VL; Cantón R; Darini ALC; Andrade LN
    Sci Rep; 2022 Apr; 12(1):6454. PubMed ID: 35440801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin combined with
    de Melo ALF; Rossato L; Velasques J; de Sousa VL; Pina Rodrigues GV; Cardoso CAL; Arantes JP; Lima BF; Simionatto S
    J Med Microbiol; 2024 Sep; 73(9):. PubMed ID: 39292222
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae.
    Huang YS; Yang JL; Wang JT; Sheng WH; Yang CJ; Chuang YC; Chang SC
    J Infect Public Health; 2024 May; 17(5):929-937. PubMed ID: 38599013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
    Elemam A; Rahimian J; Doymaz M
    J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin Resistance in Clinical Isolates of
    Conceição-Neto OC; da Costa BS; Pontes LDS; Silveira MC; Justo-da-Silva LH; de Oliveira Santos IC; Teixeira CBT; Tavares E Oliveira TR; Hermes FS; Galvão TC; Antunes LCM; Rocha-de-Souza CM; Carvalho-Assef APD
    Front Cell Infect Microbiol; 2022; 12():898125. PubMed ID: 35909953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
    Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
    Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
    Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
    Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.